Work

Redox-active Mn porphyrin-based clinical candidate, MnTnBuOE-2-PyP5+ (BMX-001) reduces paclitaxel-induced neuropathy, while suppressing ovarian cancer growth

Year: 2024

Type: article

Source: Free Radical Biology and Medicine

DOI: 10.1016/j.freeradbiomed.2024.10.117

Authors: Ivan Spasojevic, Welida Tamires Alves da Silva, Zhiqing Huang, Weina Duan, Li Du, Cathleen Chen, Jie Cao, Shasha Zhang, Hannah Lee, Gaomong Lo, Jihua Feng, Bella Mendieta, Artak Tovmasyan, Huaxin Sheng, Ines Batinic-Haberle, Angeles Alvarez Secord

Institutions: Duke University, Duke Medical Center, Duke Cancer Institute, Barrow Neurological Institute

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404381850

FWCI: 0.312

Cites:

Cited by: 2

Related to: 10